PharmiNews

The Directory of Pharma Companies and News

Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.
Category:
Category:

Valeant News

DateNews
2015-12-28Valeant Announces J. Michael Pearson Will Be On Medical Leave of Absence
2015-12-16Valeant Provides Financial Guidance Update
2015-12-15Valeant Announces New U.S. Fulfillment Agreements With Walgreens; Plans To Further Extend Distribution To Independent Ph...
2015-11-20Valeant To Hold Investor Day On December 16
2015-11-20Valeant To Hold Investor Day On December 16 (Updated)
2015-11-12Valeant Pharmaceuticals To Present At Industry Conference
2015-11-09Valeant To Hold Conference Call For Investors To Provide Business Update
2015-11-06Valeant Issues Statement On Sales Of Company Stock
2015-10-30Former Deputy Attorney General Appointed To Advise Valeant's Ad Hoc Committee
2015-10-30Valeant To Terminate Relationship With Philidor
2015-10-26Statements Of J. Michael Pearson, Chairman And CEO, And Robert Ingram, Lead Outside Director Of Valeant Pharmaceuticals
2015-10-26Valeant Pharmaceuticals Confirms Appropriateness Of Accounting, Appoints Ad Hoc Board Committee To Review Philidor
2015-10-26Valeant Pharmaceuticals Announces The Addition Of G. Mason Morfit To Its Board Of Directors
2015-10-22Valeant Pharmaceuticals To Hold Investor Conference Call On October 26, 2015
2015-10-21Valeant Pharmaceuticals Responds To Erroneous Report
2015-10-15Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Synergetics USA, Inc.
2015-10-15Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Synergetics USA, Inc.
2015-10-14Valeant Provides Update Regarding Government Inquiries
2015-10-13Valeant Pharmaceuticals Celebrates the Manufacturing of Four Billion Bottles of Eye Care Products at Bausch + Lomb's Gre...
2015-10-05Valeant Pharmaceuticals To Announce 2015 Third Quarter Results On October 19, 2015
2015-10-05Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Synergetics...
2015-09-22Bausch + Lomb and Nicox Announce FDA Acceptance of New Drug Application for Novel Glaucoma Candidate VESNEOâ„¢ (latanopr...
2015-09-08Valeant And Progenics Announce FDA Acceptance Of NDA Submission For Oral RELISTOR®
2015-09-02Valeant Pharmaceuticals To Acquire Synergetics USA
2015-09-01Valeant And AstraZeneca To Partner On Brodalumab
2015-08-25Valeant Pharmaceuticals Announces The Addition Of D. Robert Hale To Its Board Of Directors
2015-08-20Valeant Pharmaceuticals To Acquire Sprout Pharmaceuticals
2015-07-17Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical
2015-06-24Valeant Pharmaceuticals To Announce 2015 Second Quarter Results On July 23, 2015
2015-06-23Valeant and Progenics Announce the Submission of U.S. New Drug Application for Oral RELISTOR®
2015-06-11Valeant Pharmaceuticals To Appoint Robert L. Rosiello As Chief Financial Officer
2015-05-27Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)
2015-05-19Valeant Pharmaceuticals Announces 2015 Annual Meeting Results
2015-05-12Valeant Pharmaceuticals To Webcast 2015 Annual Meeting Of Shareholders
2015-04-24RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation in Adults with Chro...
2015-04-09Valeant Pharmaceuticals To Announce 2015 First Quarter Results On April 29, 2015
2015-04-01Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021
2015-04-01Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Salix Pharmaceuticals
2015-04-01Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd.
2015-04-01Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Conv...
2015-04-01Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Conve...
2015-03-27Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares
2015-03-17Valeant Pharmaceuticals Prices Offering Of $1.45 Billion Of Common Shares
2015-03-16Valeant Pharmaceuticals Announces Offering Of $1.45 Billion Of Common Shares
2015-03-16Valeant And Salix Agree On Amended Terms To Merger Agreement
2015-03-13Valeant Announces HSR Clearance For Salix Acquisition
2015-03-13Valeant Announces Pricing Of Private Offering Of Senior Notes
2015-03-11Valeant Comments On Endo Offer To Acquire Salix
2015-03-09Valeant Announces Launch Of Private Offering Of Senior Notes
2015-02-25PROVENGE® (sipuleucel-T) Demonstrates Sustained Immune Response Two Years after Treatment in Biochemically-Recurrent Pr...
2015-02-22Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.